|
MED6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.14179999899378E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.32935892796604E-12 |
| Normal-vs-Stage2 |
1.107960E-02 |
| Normal-vs-Stage3 |
5.022800E-03 |
| Normal-vs-Stage4 |
9.196500E-02 |
| Stage1-vs-Stage2 |
2.743900E-02 |
| Stage1-vs-Stage3 |
1.757810E-02 |
| Stage1-vs-Stage4 |
9.122200E-01 |
| Stage2-vs-Stage3 |
9.960600E-01 |
| Stage2-vs-Stage4 |
4.999000E-01 |
| Stage3-vs-Stage4 |
4.965600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.3743999956809E-08 |
| Normal-vs-AfricanAmerican |
5.387600E-04 |
| Normal-vs-Asian |
7.619600E-03 |
| Caucasian-vs-AfricanAmerican |
8.459800E-01 |
| Caucasian-vs-Asian |
8.787800E-01 |
| AfricanAmerican-vs-Asian |
9.796600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5564199999929E-05 |
| Normal-vs-Female |
2.19130003031864E-09 |
| Male-vs-Female |
6.960800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.210250E-02 |
| Normal-vs-Age(41-60Yrs) |
1.68329999999939E-05 |
| Normal-vs-Age(61-80Yrs) |
5.27289999996405E-07 |
| Normal-vs-Age(81-100Yrs) |
1.313170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.175400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.714400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.464600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.236620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.155000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.519400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.33769703384246E-11 |
| Normal-vs-Grade 2 |
5.60662627435704E-14 |
| Normal-vs-Grade 3 |
5.154200E-04 |
| Normal-vs-Grade 4 |
2.079000E-01 |
| Grade 1-vs-Grade 2 |
7.961700E-03 |
| Grade 1-vs-Grade 3 |
5.59070000000217E-05 |
| Grade 1-vs-Grade 4 |
1.071170E-01 |
| Grade 2-vs-Grade 3 |
1.389180E-04 |
| Grade 2-vs-Grade 4 |
6.065000E-01 |
| Grade 3-vs-Grade 4 |
6.918800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.69708691544201E-12 |
| Normal-vs-ccB subtype |
2.215500E-03 |
| ccA subtype-vs-ccB subtype |
5.365300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.019380E-04 |
| Normal-vs-N1 |
2.658200E-01 |
| N0-vs-N1 |
7.567400E-04 |
|
|
